Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lupus retinopathy. Patterns, associations, and prognosis.

F J Stafford-Brady1, M B Urowitz, D D Gladman

  • 1University of Toronto, Rheumatic Disease Unit, Wellesley Hospital, Ontario, Canada.

Arthritis and Rheumatism
|September 1, 1988
PubMed
Summary

Systemic lupus erythematosus (SLE) can cause retinopathy, often a mild microangiopathy. However, lupus retinopathy indicates a poorer survival prognosis, especially when linked to active disease or cerebritis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Declining levels of serum chemokine (C-X-C motif) ligand 10 over time are associated with new onset of psoriatic arthritis in patients with psoriasis: a new biomarker?

The British journal of dermatology·2020
Same author

Disease course patterns in systemic lupus erythematosus.

Lupus·2018
Same author

Secukinumab provides sustained PASDAS-defined remission in psoriatic arthritis and improves health-related quality of life in patients achieving remission: 2-year results from the phase III FUTURE 2 study.

Arthritis research & therapy·2018
Same author

Hydroxychloroquine prescription trends and predictors for excess dosing per recent ophthalmology guidelines.

Arthritis research & therapy·2018
Same author

Severe brady-arrhythmias in systemic lupus erythematosus: prevalence, etiology and associated factors.

Lupus·2018
Same author

Lupus myocarditis: a single center experience and a comparative analysis of observational cohort studies.

Lupus·2018

Area of Science:

  • Ophthalmology
  • Rheumatology
  • Systemic Lupus Erythematosus (SLE) research

Background:

  • Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with potential multi-organ involvement.
  • Ocular manifestations, including retinopathy, can occur in SLE patients.
  • The clinical significance and prognostic implications of lupus retinopathy require further elucidation.

Purpose of the Study:

  • To investigate the prevalence and characteristics of retinopathy in patients with SLE.
  • To assess the visual prognosis associated with lupus retinopathy.
  • To determine the relationship between lupus retinopathy and disease activity, specific complications, and patient survival.

Main Methods:

  • Prospective study design.
  • Inclusion of 550 patients diagnosed with systemic lupus erythematosus (SLE).

Related Experiment Videos

  • Ophthalmological examination to identify and characterize retinopathy.

    • Main Results:

    • Retinopathy was identified in 41 out of 550 SLE patients (7.5%).
    • The majority of lupus retinopathy cases presented as a microangiopathy with good visual prognosis.
    • Five patients experienced vision loss due to other complications.
    • Lupus retinopathy strongly correlated with active SLE (88%) and lupus cerebritis (73%).
    • Retinopathy in SLE patients was a significant marker for decreased survival.

    Conclusions:

    • Lupus retinopathy is a notable complication in SLE patients, frequently associated with active disease.
    • While often presenting as a visually benign microangiopathy, it serves as a critical indicator of poor prognosis for overall survival.
    • Close monitoring of SLE patients for retinopathy is crucial for managing disease activity and predicting outcomes.